Unlock instant, AI-driven research and patent intelligence for your innovation.

Milk and milk products for preventing or treating heart disease

a technology for heart disease and milk products, applied in the field of milk and milk products for preventing or treating heart disease, can solve the problems of increased intake of milk, increased risk of coronary heart disease, and increased consumption of milk. the effect of intak

Inactive Publication Date: 2007-07-12
A2 MILK CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a method for producing milk that is free of β-casein A1 and contains other β-caseins, such as A2, A3, D, and E, for use in preventing or treating coronary heart disease. The method involves testing DNA or RNA from cells obtained from lactating bovines for the presence of DNA or RNA encoding β-caseins A1, B, and C, and selecting bovines that do not have any DNA or RNA encoding these β-caseins. The resulting milk is then produced from these selected bovines. The technical effect of this method is the production of a safer and more effective milk for preventing or treating coronary heart disease.

Problems solved by technology

Coronary heart disease is a major cause of death, particularly in countries where the populations are well-nourished, such as in the western world.
It is widely accepted that saturated fats found in milk are a risk factor for coronary heart disease.
However, the inventor has discovered an additional risk factor present in some bovine milk unrelated to the fat content.
What is entirely surprising is the source of the risk.
Therefore, selecting cattle on the basis of milk fat content will not identify which bovines produce the novel risk factor, namely the specific β-casein variant, in their milk.
However, these differences were very small.
Bovenhuis et. al., 1992 (Bovenhuis), highlights that there are statistical problems associated with the way in which the genotype effects on fat percentages in milk are studied and documented.
Bovenhuis points out that the analysis of the effect of a particular genotype on various characteristics of milk is complex in nature and may, among other things, be affected by other genes which may be linked to the gene under study.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Milk and milk products for preventing or treating heart disease
  • Milk and milk products for preventing or treating heart disease
  • Milk and milk products for preventing or treating heart disease

Examples

Experimental program
Comparison scheme
Effect test

example 1

ACRS Method

[0131] At least 10 hairs were pulled from the end of the tail switch of a cow so that the hook-shaped follicles were retained on the end of the removed hairs. This was achieved easily by pulling the tail hairs upward while holding the rest of the switch down. If the tail has been docked, longer hairs from the end of the docked tail or other locations on the body may be substituted. Tail hairs are preferred.

[0132] Five hair follicles from one cow were cut into a sterile 1.5 ml microfuge tube. Solution A (200 μl) was added to the tube and the tube placed in a boiling water bath for 1 5 minutes. The tube was removed and Solution B (200 μl) added followed by mixing. [0133] Solution A (200 mM NaOH) [0134] Solution B (100 mM Tris-HCl, pH 8.5 with an extra 200 mM HCl)—prepared by combining 1 M Tris-HCl, pH 8.5 (10 ml) with conc. HCl (1.67 ml) and making up to 100 ml with distilled water.

[0135] Crude DNA extract (1.5. μl) from hair follicles (prepared as above) or DNA (20-50 n...

example 2

Primer Extension Method

[0144] DNA extracts from hair follicles were prepared using the method described in Example 1. Alternatively, genomic DNA isolated by other methods can be used at a concentration at about 2.5 ng / μl.

[0145] A DNA sample (1 μl) from each of 96 animals was placed into a 96 well PCR microtitre plate (or alternatively, from each of 384 animals into a 384 well PCR plate).

[0146] For the 96 well plate, a cocktail of the following reagents was prepared in a 1.5 ml microtube. The cocktail (4 μl) was added to each well in the plate with a repeating pipette.

ReagentVolume μlWater (HPLC grade)22210× Hotstar Taq PCR buffer50containing 15 mM MgCl2HotStar Taq Polymerase (5 U / μl)425 mM MgCl220dNTP 25 mM4Forward and reverse primer mix100Forward: actggattatggactcaaagatttg (SEQ ID NO: 7)Reverse: aaggtgcagattttcaacat (SEQ ID NO: 8)(1 μM each primer)

[0147] PCR was carried out using the following protocol:

1 cycle:95° C. 15 minutes45 cycles:95° C. 20 seconds56° C. 30 seconds72° ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A milk which is free of β-casein A1 protein in the prevention or treatment of coronary heart disease is disclosed. In addition, a process for the testing of DNA from cells obtained from lactating bovines for the presence of DNA encoding certain β-casein proteins, selecting the bovines on the basis of the testing, and then milking those bovines to produce milk free of β-casein A1 for use in the prevention or treatment of coronary heart disease is disclosed.

Description

FIELD OF THE INVENTION [0001] This invention relates to the use of milk which is free of the β-casein A1 protein in the prevention or treatment of coronary heart disease. The invention also relates to the testing of DNA from cells obtained from lactating bovines for the presence of DNA encoding certain β-casein proteins, selecting the bovines on the basis of the testing, and then milking those bovines to produce milk free of β-casein A1 for use in the prevention or treatment of coronary heart disease. BACKGROUND OF THE INVENTION [0002] Coronary heart disease is a major cause of death, particularly in countries where the populations are well-nourished, such as in the western world. Many factors are implicated as risk factors for this disease including obesity, smoking, genetic predisposition, diet, hypertension, and cholesterol. [0003] Dairy products, especially milk, are a major contributor to the dietary intake of humans, again particularly in western world populations. Milk contai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01K67/027A61K35/20A23C9/20A23G9/32A23G9/40A23J1/20A23L1/305A23L13/00A23L13/20
CPCA23C9/20A23G9/40A23J1/202A61K35/20A23L1/31A23L1/312A23L1/3056A23L33/19A23L13/00A23L13/20
Inventor MCLACHLAN, CORRAN NORMAN STUART
Owner A2 MILK CO LTD